YUWIN-Stroke: earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke

Sponsor
Rennes University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05884762
Collaborator
Fondation de l'Avenir (Other)
40
1
2
17.1
2.3

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effect of early rehabilitation treatment by electroencephalographic neurofeedback on upper limb motor function after stroke.

Researchers will compare :

Interventional group: electroencephalographic neurofeedback + traditional reference rehabilitation programme Control group: SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme

Condition or Disease Intervention/Treatment Phase
  • Other: electroencephalographic neurofeedback
  • Other: SHAM electroencephalographic neurofeedback
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
The occupational therapist who will include and do the sessions will be open. The assessors who will test motor functions during the assessments will be blind
Primary Purpose:
Treatment
Official Title:
earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2025
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional group

electroencephalographic neurofeedback + traditional reference rehabilitation programme

Other: electroencephalographic neurofeedback
The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance). Calibration phase at rest. Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm. In the Neurofeedback group, the patient will receive visual feedback of a virtual hand moving on a computer screen in front of him/her, depending on his/her brain activations. He will also receive haptic feedback (vibrations) in the flexor muscles of his wrist.

Sham Comparator: Control group

SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme

Other: SHAM electroencephalographic neurofeedback
The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance). Calibration phase at rest. Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm. In the SHAM group, the visual feedback and haptic feedback are randomly generated

Outcome Measures

Primary Outcome Measures

  1. Measurement of motor impairment by the Fugl-Meyer Assesment - Upper Extremity [28 days]

    Measurement of motor impairment by the Fugl-Meyer Assesment - Upper Extremity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Unilateral ischaemic or haemorrhagic stroke

  • Adult (18-80 years), both sexes

  • Stroke < 3 weeks

  • Upper limb deficit defined by Shoulder Abduction Finger Extension score <5 on day 3 of stroke; i.e., patients predicted to have incomplete recovery

  • No participation-limiting comprehension problems

  • With or without homonymous lateral hemianopia; with or without visuospatial hemineglect

  • Free, informed and written consent signed by the patient or a member of the patient's family (in the case of a patient who is able to understand the information and give consent but has motor difficulties resulting in an invalid signature).

  • Affiliated to french social security

Exclusion Criteria:
  • Ischemic or hemorrhagic brain stem and/or cerebellum involvement

  • Multiple strokes

  • Stroke < 1 week; in order not to be deleterious by starting active rehabilitation too early after immediate stroke

  • Aphasia with major comprehension impairment

  • Contraindication to MRI

  • pacemaker or implantable defibrillator,

  • neurosurgical clips,

  • cochlear implants,

  • intra-orbital or encephalic metallic foreign bodies,

  • stents placed less than 4 weeks ago and osteosynthesis devices placed less than 6 weeks ago,

  • claustrophobia.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rennes Chu Rennes France 35000

Sponsors and Collaborators

  • Rennes University Hospital
  • Fondation de l'Avenir

Investigators

  • Principal Investigator: Simon BUTET, MD, Rennes CHU

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT05884762
Other Study ID Numbers:
  • 35RC22_9743_YUWIN-Stroke
  • 2023-A01150-45
First Posted:
Jun 1, 2023
Last Update Posted:
Jun 1, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rennes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2023